-
Something wrong with this record ?
Vliv dlouhodobého užívání pervitinu na metabolismus vápníku a fosforu v kostech
[Effect of long-term pervitine abude on calcium and phosphorus metabolism]
Soňa Jirsáková, Richard Pikner, Václav Vyskočil
Language Czech Country Czech Republic
- Keywords
- Pervitin,
- MeSH
- Densitometry methods MeSH
- Bone and Bones metabolism MeSH
- Bone Density drug effects MeSH
- Humans MeSH
- Osteoporosis chemically induced blood MeSH
- Phosphorus Metabolism Disorders chemically induced MeSH
- Calcium Metabolism Disorders chemically induced MeSH
- Amphetamine-Related Disorders metabolism MeSH
- Check Tag
- Humans MeSH
Ten patients previously taking pervitine (for 8.8 years on average) showed a decrease in the body mass index, 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol concentrations and an increase in bone alkaline phosphatase; the other examined parameters remained unchanged. The bone mineral density showed low and very low values in five and four patients, respectively, related to the Z-score according to NHANNES III tables in a U.S. reference study. There are several reasons, other than the pervitine intake, why the patients could have low bone mineral density and calcium-phosphorus metabolism disorders: low calcium and vitamin D intake, lack of body exercise, nicotine and alcohol abuse.
Effect of long-term pervitine abude on calcium and phosphorus metabolism
Lit.: 14
- 000
- 02612naa 2200433 a 4500
- 001
- bmc07509136
- 003
- CZ-PrNML
- 005
- 20111210123423.0
- 008
- 080922s2008 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Jirsáková, Soňa. $7 _BN005828
- 245 10
- $a Vliv dlouhodobého užívání pervitinu na metabolismus vápníku a fosforu v kostech / $c Soňa Jirsáková, Richard Pikner, Václav Vyskočil
- 246 11
- $a Effect of long-term pervitine abude on calcium and phosphorus metabolism
- 314 __
- $a 2. interní klinika, Osteocentrum, FN, Plzeň-Bory
- 504 __
- $a Lit.: 14
- 520 9_
- $a Ten patients previously taking pervitine (for 8.8 years on average) showed a decrease in the body mass index, 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol concentrations and an increase in bone alkaline phosphatase; the other examined parameters remained unchanged. The bone mineral density showed low and very low values in five and four patients, respectively, related to the Z-score according to NHANNES III tables in a U.S. reference study. There are several reasons, other than the pervitine intake, why the patients could have low bone mineral density and calcium-phosphorus metabolism disorders: low calcium and vitamin D intake, lack of body exercise, nicotine and alcohol abuse.
- 650 _2
- $a kosti a kostní tkáň $x metabolismus $7 D001842
- 650 _2
- $a osteoporóza $x chemicky indukované $x krev $7 D010024
- 650 _2
- $a poruchy metabolismu vápníku $x chemicky indukované $7 D002128
- 650 _2
- $a poruchy metabolismu fosforu $x chemicky indukované $7 D010760
- 650 _2
- $a poruchy spojené s užíváním amfetaminu $x metabolismus $7 D019969
- 650 _2
- $a kostní denzita $x účinky léků $7 D015519
- 650 _2
- $a denzitometrie $x metody $7 D003720
- 650 _2
- $a lidé $7 D006801
- 653 00
- $a Pervitin
- 700 1_
- $a Pikner, Richard $7 xx0053349
- 700 1_
- $a Vyskočil, Václav $7 hka2010562188
- 773 0_
- $w MED00011010 $t Chemické listy $g Roč. 102, č. 5 (2008), s. 353-357 $x 0009-2770
- 856 41
- $u http://chemicke-listy.cz/docs/full/2008_05_353-357.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 1918 $c 395 $y 1
- 990 __
- $a 20080919102749 $b ABA008
- 991 __
- $a 20080922103442 $b ABA008
- 999 __
- $a ok $b bmc $g 624730 $s 477165
- BAS __
- $a 3
- BMC __
- $a 2008 $b 102 $c 5 $d 353-357 $i 0009-2770 $m Chemické listy $x MED00011010
- LZP __
- $a 2008-23/ipmv
